Member Info for VikR

The patent has had its issue notification today which serves as confirmation that it will now be granted. Before it is officially announced via RNS now is the time to load up on this share like never before. For those with spare funds strongly suggest you invest into here. FAB has never really been a share for a short term gain but this here is almost a certainty for the swing traders amongst you. I myself have taken out some other shares to buy back in this morning. Also got tempted to break an instant access savings account pot at a rate of 4.33% and make some sizeable buys this morning. Hope you astute investors all do well and good luck ALTHs

Came across this share on another group a few days ago so decided to buy a million plus and take the plunge. Hopefully it proves to be a wise decision given the sentiment on these boards of upcoming news flow. On another note also pumped £15k into FAB fusion antibodies this morning as they have announced an issue notification of the patent grant on the USA website so getting in there before it is officially announced via RNS. Best of luck all and hope we excel here

Got the itch to buy big this morning so have gone all in with multi million buys managed to get below 0.1. This is not my sector but hopefully it will prove to be a wise decision. On another note check out FAB fusion antibodies just checked another £15k in there patent showing as approved on the USA website so getting in before it is formally announced via RNS

Good to buy in this dip now in anticipation of what is around the corner with patent pending news and subsequent deals on the back of this. It seems FAB fusion antibodies is also awaiting the same patent approval very imminent. Perhaps you can use that as a comparator to see what a patent approval does to the SP

Will be moving some funds around tomorrow to buy some more on existing substantive holdings first thing. If there was ever time on the cusp of huge patent news it is now. Load up astute investors and sit back and let the market do the rest

Morning astute investors,

We now have after a patient wait the alignment of the above. So unless something drastic happens from left afar expect steady rising in a unilateral direction to the upside. This is FABs time and no one deserves it more then my fantastic scientific colleagues behind the scenes who’s tech has made this happen. Long live British pioneering science.

Hi astute investors,

There is work gearing up to ensure the patent filing is as robust as possible with the new breakthrough findings earlier this year. This is essential prerequisite to any deal which can be negotiated. The scientific team are working hard in the background as Imm know all too well from historical experience with incanthera the importance of getting this absolutely correct. This is running parallel with ongoing commercial talks however no Pharma is going to want to commit and sign on the dotted line until the patent is wholly prepared and filed. Therefore scientific team and patent lawyers are working in tandem but as with anything these things take time. As Tim said in the AGM though expect this to conclude this year and a deal to be signed. The facts still remain the same P140 is a safe non immunosuppressive agent and now with also diagnostic capabilities as well as therapeutic. As a pharmacist interested in the science it won’t work for all patients but there is enough it will work for to make it a commercial success. Good luck ALTHs and DYOR to satisfy yourself of the science behind the product you invest in

When Dr Kinkaid alludes to a surprise coming our way he genuinely means it. Normally being a conservative neutral scientist this ‘arms to sleeves’ comment means expect the unexpected and it’s going to be huge

Hi

Thanks for pointing out my grammatical error, apologies .These are all my own perceptions on the current state of play here at Fusion antibodies and I am confident in the end goal. I must profess I am no subject matter expert though so DYOR and background due diligence

In order for an antibody to work in needs to bind to its host site and induce an immune response in that cell. In summary the effort FAB makes into its research-development to implementation process makes the failure rate very small. This means when they discover the right antibody for there desired target the chance of reproducing it on a grand scale and making sure it is therapeutic( ie does its intended job) is extremely high. There current technology affords them the opportunity to be able to do this. But make no mistake this is no given, it has taken a group effort of all there great team over the years to get to such a stage. People who buy now won’t get such a chance again to buy at these levels probably, that is of course until they invent the next best thing as part of the scientific evolvement of tech.

I have done research into the scientific aspects of this company in great detail. The scientists involved behind the scenes are true innovators and pioneers in the therapeutic antibody field. They now have infinite resources & can invest in equipment that at one time was not affordable & within their reach. Pinpoint accuracy of antibodies, precision of targets and reproducibility in bulk are key in this game, fab now has the machinery to make that happen. Must also note that I am surprised the veterinary market branch hasn’t given us any news yet , that’s another huge under explored avenue for felinisation and caninisation of antibodies.

I have brought into Ron Jon leading the helm and it’s only a matter of time he steers us to success. Unfortunately during that journey you have to ride the downward trends whilst PIs sell out on no news. Patience is key here and realistic expectations of timelines. In the interim FAB fusion antibodies gets ready to multi bag on imminent news, albeit a different sector but worthy of investment for those with spare funds. Good luck to ALTHs and wish you and your loved ones prosperity on your journey.

Morning everyone

Do not miss the valuable opportunity that awaits you here. Having done a sizeable amount of research on this company and being a fellow pharmacist fortunate to graduate with a first class honours albeit many years ago I am extremely confident in the optimal tech. The rest of their products are also refined versions of competitor offerings but optimal is the premium that sets this apart. Become a part of history in the recovery transition of this share. Welcome to any new investors on board and feel free to dig in deeper to acquire your own knowledge and confidence in the company.

At this stage we can only take encouragement from the analogy no news means hard work happening in the background which will hopefully take all the skeptics by surprise once released. In the interim we all need some cash flow certainty and I believe FAB fusion antibodies is the next multi-bagger to rerate exponentially. Homegrown British talent hopefully leads the way on the worldwide biotech & pharmaceutical platform. Good luck to ALTH and any newbies considering investing in the sector

Just heard the investor meet from CEO Anthony Tennyson a few days and what an eloquent well pitched introduction to the company for newbie investors like me. As a fellow pharmacist the offering undoubtedly ticks all the boxes and it is a case of when not if the major pharma deals will be concluded. Similar to FAB shares over at Fusion antibodies which is also getting ready for to explode. A good time for UK pharmaceutics and biotech with our homegrown scientific talent innovating and leading the worldwide platform

Fellow investors this is the best time to invest in a promising share like this. When the market is silent we need to load up and enjoy the journey upwards. When it is already in double/ triple figures banking the rise is a missed opportunity. So fellow investors the time is now to accumulate, sit back and await the imminent news flow. It will happen before the end of 2025 so not long to go folks

We have 5 offerings to present to the market, in the words of our CEO most business organisations survive on just the one, let that sink in

When the news lands of validation completion, patent approval and new contracts we will explode exponentially. As a fellow pharmacist huge believer of there groundbreaking antibody technologies, some very talented scientists within FAB indeed

Great to see the turnaround with this, as a clinical pharmacist prescriber we have been reliant on prostate examination clinical findings and the limitations of PSA bloods for far too long when suspecting cancer in patients presenting with typical urinary symptoms. If the government also rolls it out as a national screening programme in the future game changer. Also nice to see FAB fusion antibodies which has a similar MCAP about to experience a similar journey with patent pending approval around the corner and flagship tech. Proud to see the UK scientists paving the way and making international waves

Nice to see the contracts are coming through regularly but having brought on the spike at over 1p this doesn’t seem to want to shift. I’m in it for the long haul though as the work they do is only going to get more in demand going forward, as a pharmacist I can see its firm place in the industry. On another note FAB fusion antibodies is also looking to rocket any day with patent pending around the corner on flagship tech, a great time all round for the British pharmaceutical/biotech leading organisations.

Just heard the investor meet from CEO Anthony Tennyson a few days and what an eloquent well pitched introduction to the company for newbie investors like me. As a fellow pharmacist the offering undoubtedly ticks all the boxes and it is a case of when not if the major pharma deals will be concluded. Similar to FAB shares over at Fusion antibodies which is also getting ready for to explode. A good time for UK pharmaceutics and biotech with our homegrown scientific talent innovating and leading the worldwide platform